Gamma Investing LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 664 shares of KALV stock, worth $5,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
664
Previous 59
1025.42%
Holding current value
$5,511
Previous $683,000
723.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KALV
# of Institutions
126Shares Held
47.9MCall Options Held
551KPut Options Held
110K-
Vr Adviser, LLC New York, NY6.25MShares$51.9 Million7.5% of portfolio
-
Tang Capital Management LLC San Diego, CA4.32MShares$35.9 Million4.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.21MShares$35 Million1.92% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$33.2 Million3.51% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$30.6 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $204M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...